Desert Oasis Healthcare Partners with Rimidi to Help Improve Asthma Management for Patients using Teva Digihaler® Technology | Rimidi
Teva to Slim Down Generic Drug Business as It Seeks Turnaround. The Stock Is Up. | Barron's
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion | Business Wire
Insilico collaborates with Teva on AI system | EurekAlert!
Teva Pharmaceutical Industries Ltd. - YouTube
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Teva Pharmaceuticals Industries
Teva Pharmaceuticals on Twitter: "@Kgen68992973 To report an adverse event with a Teva product, please call our Medical Info Center 1-888-838 2872 or email drug.safety@tevapharm.com." / Twitter
Teva Pharmaceutical Industries Ltd. - Home | Facebook
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA